UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 368

Sortiert nach

Serum Circulating Human mRNA Profiling and Its Utility for Oral Cancer Detection

Journal of clinical oncology, 2006-04, Vol.24 (11), p.1754-1760

2006

Volltextzugriff (PDF)

Preventing complications: Hepatitis B screening in cancer patients undergoing systemic therapy

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.237-237

2019

Volltextzugriff (PDF)

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4540-4540

2022

Volltextzugriff (PDF)

EFIRM liquid biopsy (eLB) : D etection of ultra-short circulating tumor DNA (usctDNA) in plasma and saliva of non-small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24062-e24062

2018

Volltextzugriff (PDF)

EFIRM liquid biopsy (eLB) to detect actionable mutations in NSCLC

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.8520-8520

2016

Volltextzugriff (PDF)

Technical validation of the electric field-induced release and measurement (EFIRM) assay for the detection of EGFR mutations in circulating cell free DNA in plasma and saliva

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e24172-e24172

2018

Volltextzugriff (PDF)

Clinical validity of electric field induced release and measurement (EFIRM) for KRAS mutation detection in circulating DNA associated with pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15702-e15702

2016

Volltextzugriff (PDF)

Electric field release and measurement (EFIRM) method for robust and rapid quantification of micro-RNA cancer biomarkers

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23163-e23163

2016

Volltextzugriff (PDF)

Local ablative therapy (LAT) for oligoprogressive, EGFR -mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20545-e20545

2017

Volltextzugriff (PDF)

Liver Failure After Abdominal Irradiation: Identifying the Right Suspects

Journal of clinical oncology, 2016-03, Vol.34 (9), p.e80-e83

2016

Volltextzugriff (PDF)

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2282-2292

2001

Volltextzugriff (PDF)

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1963-1972

2010

Volltextzugriff (PDF)

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Journal of clinical oncology, 2019-05, Vol.37 (14), p.1228-1263

2019

Volltextzugriff (PDF)

Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2094-2101

2012

Volltextzugriff (PDF)

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2437-2443

2006

Volltextzugriff (PDF)

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1620-1627

2012

Volltextzugriff (PDF)

Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3284-3290

2014

Volltextzugriff (PDF)

Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy

Journal of clinical oncology, 2006-10, Vol.24 (30), p.4895-4900

2006

Volltextzugriff (PDF)

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Journal of clinical oncology, 2023-03, Vol.41 (7), p.1453-1465

2023

Volltextzugriff (PDF)

Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab

Journal of clinical oncology, 2007-08, Vol.25 (22), p.3230-3237

2007

Volltextzugriff (PDF)

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies

Journal of clinical oncology, 2008-12, Vol.26 (35), p.5668-5670

2008

Volltextzugriff (PDF)

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4057-4065

2017

Volltextzugriff (PDF)

Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1395-1400

2010

Volltextzugriff (PDF)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

Journal of clinical oncology, 2021-06, Vol.39 (17), p.JCO2002903-1864

2021

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(365)

Publikationsform

Artikel
(368)

Sprache

Englisch
(368)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Oncology
(53)
Humans
(52)
Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Female
(39)
Male
(38)
Middle Aged
(33)
Aged
(29)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Adult
(23)
Original Reports
(21)
Tumors
(21)
Aged, 80 And Over
(16)
Treatment Outcome
(16)
Neoplasm Staging
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Disease-Free Survival
(9)
Prospective Studies
(9)
Predictive Value Of Tests
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serum Circulating Human mRNA Profiling and Its Utility for Oral Cancer Detection

Preventing complications: Hepatitis B screening in cancer patients undergoing systemic therapy

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) compared to computed tomography (CT) for advanced renal cell carcinoma (RCC)

EFIRM liquid biopsy (eLB) : D etection of ultra-short circulating tumor DNA (usctDNA) in plasma and saliva of non-small cell lung cancer (NSCLC) patients

EFIRM liquid biopsy (eLB) to detect actionable mutations in NSCLC

Technical validation of the electric field-induced release and measurement (EFIRM) assay for the detection of EGFR mutations in circulating cell free DNA in plasma and saliva

Clinical validity of electric field induced release and measurement (EFIRM) for KRAS mutation detection in circulating DNA associated with pancreatic ductal adenocarcinoma

Electric field release and measurement (EFIRM) method for robust and rapid quantification of micro-RNA cancer biomarkers

Local ablative therapy (LAT) for oligoprogressive, EGFR -mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib

Liver Failure After Abdominal Irradiation: Identifying the Right Suspects

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy

Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab

Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

Aktive Filter

Suchergebnisse filtern